Type I transglutaminase is a plasma membrane-anchored intracellular protein-protein crosslinking enzyme that is responsible for assembly of the keratinocyte cornified envelope during terminal keratinocyte differentiation. We recently described a novel protein, TIG3, that when expressed in keratinocytes causes increased transglutaminase activity and keratinocyte cell death. However, the mechanism of activation of transglutaminase by TIG3 is not known. We now extend our previous study and show that full-length TIG3 forms a complex with type I transglutaminase that is demonstrated by TIG3-transglutaminase co-precipitation. We also demonstrate that treating TIG3-expressing cells with monodansyl cadaverine, a competitive transglutaminase substrate, attenuates the TIG3-dependent response, suggesting that transglutaminase is an important mediator of TIG3 action. These findings suggest that TIG3 forms a complex with transglutaminase resulting in transglutaminase activation and that transglutaminase activity is required for the TIG3-dependent biological response.
Introduction
Transglutaminases catalyze the formation of interprotein e-(g-glutamyl)lysine bonds that function to stabilize proteins, cells, structures and tissues (Lorand and Graham, 2003) . Although transglutaminase activity is tightly controlled, the mechanisms that regulate activity are not completely understood. Calcium is a required cofactor for transglutaminase crosslinking activity and calcium binding sites exists on the transglutaminase proteins (Casadio et al., 1999; Ahvazi et al., 2002 . Binding of calcium positions the catalytic site in an active conformation and increased extracellular calcium level increases transglutaminase activity (Hennings et al., 1981; Greenberg et al., 1991; Kasturi et al., 1993; . GTP also regulates some members of the transglutaminase family (TGase 2, 3, and 5). The binding of GTP alters the conformation of these enzymes to cause release of the calcium cofactor to terminate transglutaminase crosslinking activity (Zhang et al., 1998; Ahvazi et al., 2002; Candi et al., 2004) .
Epidermal keratinocytes express several transglutaminase isoforms. Type 1 transglutaminase (TG1) is an important form that is required for successful assembly of the cornified envelope. Reduced expression of this enzyme is a major underlying cause of lamellar ichthyosis (Huber et al., 1995) . The cornified envelope consists of individual proteins that are held together via interprotein covalent crosslinks (Rice and Green, 1977; Eckert et al., 1997; Kalinin et al., 2002) . Lipids are also covalently incorporated into this structure; thus, helping make the structure impermeable to water (Wertz et al., 1989) . This structure is assembled adjacent the inner surface of the plasma membrane during the terminal stages in keratinocyte differentiation and serves a major role in epidermal barrier formation (Eckert, 1989; Eckert et al., 1993; Nemes and Steinert 1999; Steinert and Marekov 1999) . Envelope assembly is mediated by TG1. TG1 is unique in that it possesses an amino-terminal lipid linkage that anchors it to the inner surface of the plasma membrane, the location of cornified envelope assembly (Phillips et al., 1993; Steinert et al., 1996) . TG1 activity is influenced by the presence of calcium ions (Hennings et al., 1981; Kasturi et al., 1993; Nemes et al., 1999b ) but TG1 does not have GTPase activity and is not regulated by guanine nucleotides.
In a recent report, we characterized a protein, TIG3, that regulates keratinocyte survival (Sturniolo et al., 2003) . These findings suggest that it does so by regulating transglutaminase activity. We now show that TIG3 markedly increases transglutaminase activity without substantially changing transglutaminase level and that transglutaminase activation is associated with formation of a TIG3-TG1 complex. Moreover, inhibition of transglutaminase interaction with endogenous substrates attenuates the TIG3-associated changes in cell morphology and survival, suggesting that transglutaminase-dependent crosslinking is required for the TIG3-dependent responses.
Results and discussion

TIG3 expression leads to a loss of keratinocyte viability
As shown in Figure 1a , infection of normal human keratinocytes with TIG3 1-164 expression vector results in an accumulation of TIG3 in cells. Concomitant with this accumulation is a reduction in cell survival such that only 15% of cells are viable after 5 days (Figure 1b) . In contrast, empty vector-infected cells remain viable. The loss of cell viability is associated with formation of cell ghosts that are resistant to washing with detergent ( Figure 1c) . Figure 1d shows the morphology of cells after 5 days of tAd5-EV or tAd5-TIG3 1-164 exposure. Cells from each group were gently washed with phosphate-buffered saline and then incubated with 1 ml of 1 : 1 phosphate-buffered saline (PBS)/0.4% (w/v) trypan blue solution (Sigma, T8154) for 5 min at 371C and then washed twice in PBS. Trypan blue-positive and total cells were counted in three microscopic fields for three experiments and presented as percent viable cell number. The error bars represent the mean7s.e.m. (c) TIG3 expression promotes formation of detergent-resistance structures. Cells from each treatment group were washed with PBS and then incubated at 251C for 5 min in situ with 200 ml of extraction buffer (100 mM Tris-HCl pH, 7.4, 10 mM EDTA, 0.1% SDS, 5 mM b-mercaptoethanol) per 20 cm 2 plate. Cell-like structures surviving the incubation were counted and the count displayed as a percent of total cell number. The error bars represent the mean7s.e.m. (d) TIG3 expression promotes formation of detergent-resistant structures. Each photograph is a brightfield image of keratinocytes taken following 5 days of tAd5-EV or tAd5-TIG3 1-164 expression followed by a 5 min treatment without (ÀSDS) or with ( þ SDS) extraction buffer Control cells (tAd5-EV) remain healthy and viable in the absence of detergent treatment (ÀSDS); however, a 5 min treatment with detergent ( þ SDS) causes complete lysis. Cells expressing TIG3 1-164 , in contrast, are reduced in number and display a distorted morphology in the absence of detergent treatment (ÀSDS). In addition, these structures survive exposure to detergent and the number of these detergent-resistant ghosts increases steadily until they comprise nearly 100% of TIG3 1-164 -expressing cells after five days (Figure 1c ). These findings suggest that these structures are a product of transglutaminase activity.
TIG3 expression regulates transglutaminase activity
We next assessed the impact of TIG3 expression on the extent of transglutaminase activation. Cell were infected with TIG3-encoding or empty adenovirus and at 48 h postinfection extracts were prepared in lysis buffer and equal amounts of protein were incubated in the presence ( þ ) of Biotin-X-cadaverin (BC) in 0.8 mM calciumsupplemented reaction buffer. Samples of reaction mixture were then precipitated using avidin-agarose, and blotted with avidin-HRP. As shown in Figure 2a , extracts prepared from TIG3-expressing cells manifest a markedly higher level of transglutaminase activity as compared to cells infected with empty vector (EV). It should be noted that BC incorporation is observed in extracts prepared from empty vector-infected cells; however, this is only apparent when the film is overexposed (not shown).
This increase in transglutaminase activity could be due to an increase in activity or to an increase in transglutaminase level. Immunoblots of TG1 protein, although poor due to the less than optimal performance of the available antibody, revealed a slight increase in TG1 level in extracts prepared from TIG3-expressing cells as compared to EV-infected cells (not shown). To further assess this, we measured the amount of TG1 mRNA in keratinocytes following a 24 h treatment in the presence of empty vector or TIG3-encoding vector ( Figure 2b ). RT-PCR detection of TIG3 mRNA reveals the presence of endogenous TIG3 mRNA in EVinfected cells and a substantial increase in TIG3 mRNA in cells infected with TIG3-encoding adenovirus. We also detect a slight twofold increase in TG1 mRNA in cells infected with TIG3-encoding adenovirus. However, this minimal increase in TG1 level does not account for the dramatic increase in transglutaminase activity observed in Figure 2a . In addition, as controls, we show that neither involucrin nor b-actin mRNA levels are regulated by TIG3.
Transglutaminase crosslinking of endogenous substrates is required for TIG3-dependent biological response A second important question is whether transglutaminase is the major or sole mediator of the TIG3-dependent response. To assess this, keratinocytes were infected with tAd5-EV or tAd5-TIG3 1-164 , and then treated with monodansylcadaverine (MDC). MDC is a cell permeable transglutaminase substrate that competes with endogenous TG substrates (Oliverio et al., 1997; Singh et al., 2003) and suppresses protein-protein crosslink formation. As shown in Figure 3a , MDC treatment reverses the TIG3 1-164 -dependent cell mortality. In addition, we examined the effects of MDC treatment on cell morphology. In the absence of MDC, the TIG3 1-164 -expressing keratinocytes assume a characteristic flattened morphology. Interestingly, this morphological change can be attenuated by the presence of MDC (Figure 3b ). In contrast, the morphology of empty vector-infected cells is not markedly altered in the presence or absence of MDC. This result suggests that interfering with transglutaminase action attenuates TIG3-associated responses and that transglutaminase is an important mediator of TIG3 action.
Evidence for TIG3 interaction with TG1
An important question is the mechanism whereby TIG3 activates transglutaminase and promotes morphology change. One possibility is that TIG3 forms a complex with TG1. To test this hypothesis, TIG3 1-164 and TG1-FLAG were expressed in keratinocytes and interaction 2 dishes in KSFM were infected with 5 MOI of Ad5-TA with 25 MOI of tAd5-EV or tAd5-TIG3. Whole-cell extracts were prepared in lysis buffer at 48 h postinfection and 50 mg protein was incubated in the presence or absence of 4 mM biotin-x-cadaverine (BC) for 1 h at 371C. Biotinylated proteins were collected by streptavidin-agarose precipitation. The bound proteins were eluted and 25 mg protein equivalents (based on the starting protein sample) were electrophoresed on a 10% acrylamide gel. No biotinylated proteins were detected in control groups incubated in the absence of BC (not shown). The blot was incubated with avidin-HRP (ExtrAvidin, Sigma) and the asterisk indicate the range of biotin-labeled proteins. Prolonged exposure revealed biotin-labeled proteins in the EV extract, but the level was far below that observed in the TIG3 extract. This experiment was repeated four times with essentially identical results. (b) Subconfluent primary human keratinocytes, growing on 20 cm 2 dishes, were infected with 25 MOI of either tAd5-TIG3 1-164 or tAd5-EV in the presence of 5 MOI of Ad5-TA. At 24 h postinfection, the cells were harvested and mRNA was prepared. The indicated mRNAs were detected by RT-PCR was assayed by immunoprecipitation. We first confirmed expression of both proteins. Immunoblot of total cell extract confirms that TG1-FLAG (upper panel) and TIG3 1-164 (middle panel) are expressed ( Figure 4a ). TIG3 1-164 is present as a monomer (arrow) and as a high molecular weight form (asterisk). The b-actin immunoblot confirms the equal loading of samples. To assay for TIG3 1-164 /TG1 interaction, TG1-FLAG was precipitated with anti-FLAG and the collected products were electrophoresed for immunoblot. Figure 4b confirms (upper panel) that anti-FLAG precipitates TG1-FLAG. The lower panel demonstrates that TIG3 1-164 monomer, and a higher molecular weight TIG3-immunoreactive band (asterisk), co-precipitate with TG1-FLAG. This interaction is TG1-FLAG specific, as TIG3 is not precipitated from extracts lacking TG1-FLAG. As a control, we studied the interaction of a known cornified envelope precursor, involucrin (Rice and Green, 1979; Robinson et al., 1996) , with TG1-FLAG (Figure 4c ). Cells were transfected with TG1-FLAG and/or TIG3 1-164 and after 24 h total extracts were prepared for analysis. The upper panel is an immunoblot of total cellular extract that confirms that endogenous involucrin is present. In the lower panel, TG1-FLAG was precipitated using the anti-FLAG antibody, and the blot was incubated with an involucrin-specific antibody. This immunoblot shows that involucrin does not coprecipitate with TG1-FLAG.
Lack of interaction of TIG3 truncation mutant with TG1 correlates with lack of biological response
To further examine the requirement for TIG3/TG1 interaction for the biological response, we compared the interaction of TG1 with TIG3 1-134 versus TIG3 1-164 . TIG3 1-164 is the full-length protein, while TIG3 1-134 lacks the thirty amino-acid carboxy-terminal hydrophobic domain that directs TIG3 to membranes (Sturniolo et al., 2003) . The upper panel in Figure 5a is an immunoblot showing that TG1-FLAG, TIG3 1-134 and TIG3 1-164 are expressed in keratinocytes transfected with plasmids encoding the corresponding proteins. The lower panel shows that TG1-FLAG is precipitated from total cell extracts using anti-FLAG and that TIG3 1-164 but not TIG3 1-134 co-precipitates with TG1-FLAG. This suggests that TIG3 1-134 does not interact with TG1. To compare the biological response to TIG3 1-164 and TIG3 1-134 , we monitored the ability of each to alter cell morphology. Dramatic morphological change is observed in cells expressing TIG3 1-164 ; however, no change is produced by TIG3 (Figure 5b ).
TIG3 is a transglutaminase substrate
Proteins that localize in the vicinity of transglutaminase are frequently also substrates. To assess whether TIG3 1-164 , in addition to its possible regulatory role, functions as a transglutaminase substrate, keratinocytes were infected with tAd5-EV or tAd5-TIG3 1-164 . At various times of postinfection, the cells were harvested and total cell extracts were electrophoresed for detection of TIG3. As shown in Figure 6a , TIG3 1-164 monomer accumulates in cells by 24 h. In addition, high molecular weight anti-TIG3 immunoreactive material accumulates by 48 h. Much of this material remains in the stacking gel and loading well (Figure 6a ). In addition, a small amount of TIG3 dimer is formed (asterisk). As expected, TIG3 is not detected in keratinocytes infected with tAd5-EV.
An additional question is whether TIG3-dependent activation of transglutaminase results in crosslinking of previously described transglutaminase substrates. Involucrin is a well-characterized precursor of the keratinocyte cornified envelope and a reactive transglutaminase substrate (Rice and Green 1979; Robinson et al., 1996; LaCelle et al., 1998) . The middle panel in Figure 6a shows migration of the involucrin monomer (arrow). In contrast to the accumulation of crosslinked TIG3 protein observed in the upper panel, no high molecular weight involucrin complexes are present (middle panel) -indicating that involucrin is not utilized as a transglutaminase substrate under these conditions. The b-actin blot confirms (lower panel) that equivalent amounts of protein were loaded from each sample.
MDC treatment inhibits crosslinking
The results shown in Figure 3 indicate that MDC treatment attenuates the TIG3-dependent change in cell morphology. Figure 6b shows that MDC treatment also inhibits the transglutaminase-dependent incorporation of TIG3 into higher molecular weight forms. Cells, harvested 2 days after infection with empty vector, show a lack of TIG3 whether maintained in the absence or presence of 150 mM MDC. In contrast, TIG3 monomer (arrow) and high molecular weight anti-TIG3 immunoreactive material (in the stacking gel) are observed in tAd-TIG3 1-164 infected cells. Treatment with MDC results in a concentration-dependent reduction in the quantity of crosslinked product, providing evidence that inhibition of transglutaminase activity suppresses incorporation of TIG3 into crosslinked structures.
Finally, we examined the ability of the inactive TIG3 mutant, TIG3 1-134 , to serve as a transglutaminase substrate. Keratinocytes were infected with empty Figure 4 TIG3 and TG1-FLAG co-precipitate. Keratinocytes growing in 50 cm 2 dishes in KSFM were cotransfected with 5 mg of plasmids encoding TIG3 and/or TG1-FLAG. Total DNA in each transfection was adjusted to 10 mg by addition of pcDNA3-EV. At 24 h post-transfection, the cells were lysed and fractionated into total extract and supernatant. Supernatant fraction (500 mg protein) was incubated with anti-FLAG M2-agarose overnight at 4 C and the complex was then washed three times with cell lysis buffer. The precipitated proteins were then dissolved in Laemmli sample buffer and electrophoresed on a denaturing 12% acrylamide gel in parallel with total extract samples (25 mg protein). Total extract (a) or immunoprecipitate (b) were electrophoresed on a 12% denaturing polyacrylamide gel and then immunoblotted with anti-TIG3, anti-b-actin or anti-FLAG. The asterisks indicate high molecular weight TIG3-immunoreactive bands. (c) The total extract (upper panel) and supernatant (lower panel) fractions were identical to those used above. Supernatant fraction was precipitated with anti-FLAG and then electrophoresed prior to immunoblot with anti-involucrin (lower panel) Figure 5 TIG3 1-134 does not interact with TG1-FLAG. (a) Keratinocytes, grown on 50 cm 2 dishes in KSFM, were cotransfected with 5 mg each of the indicated expression vectors. At 24 h post-transfection, total extracts were prepared in lysis buffer, electrophoresed, and analysed by immunoblot with anti-FLAG, anti-TIG3 and anti-b-actin (upper panel). For immunoprecipitation, 500 mg of total cell extract was incubated overnight at 41C with anti-FLAG M2-agarose, washed three times in cell lysis buffer, and the precipitated proteins were electrophoresed for detection of FLAG-TG1 and TIG3 (lower panel) with anti-FLAG and anti-TIG3. (b) TIG3 1-134 does not cause morphological change. Brightfield images of keratinocyte at 48 h following infection with empty adenovirus or adenovirus encoding TIG3 1-134 or TIG3 1-164 adenovirus or adenoviruses encoding TIG3 1-164 or TIG3 . After 24 h, total extracts were prepared and electrophoresed for immunoblot with anti-TIG3. Figure 6c shows that TIG3 1-134 does not function as a transglutaminase substrate.
The above experiments suggest that TIG3 serves as a transglutaminase substrate. To provide direct evidence, we used a small molecule amine-donor transglutaminase substrate, biotin-X-cadaverine (BC). Cultured keratinocytes were infected with either a TIG3 1-164 -encoding or empty adenovirus. At 48 h postinfection, cells were homogenized in lysis buffer and equal amounts of extract were incubated in the presence ( þ ) or absence (À) of BC in 0.8 mM calcium-supplemented buffer. BC-labeled proteins were then collected using avidinagarose beads. Bound material was then eluted in SDS sample buffer, electrophoresed and immunoblotted with anti-TIG3. Figure 7 provides direct evidence that TIG3 1-164 functions as an amine acceptor/glutamyl donor.
TG1 and TIG3 in keratinocytes
TG1 is the key enzyme that catalyses formation of the protein-protein crosslinks during cornified envelope assembly in keratinocytes (Goldsmith and Martin, 1975; Ogawa and Goldsmith, 1976 ; Huber et al., Whole-cell extracts were prepared in lysis buffer at 48 h postinfection and 50 mg of protein was incubated in the presence or absence of 4 mM biotin-x-cadaverine (BC) for 1 h at 371C. Biotinylated proteins were collected by streptavidin agarose precipitation. The bound proteins were eluted and 25 mg protein equivalents (based on the starting protein sample) were electrophoresed on a 10% acrylamide gel. No biotinylated proteins were detected in control groups incubated in the absence of BC (not shown). The blot was incubated with anti-TIG3 and the asterisk indicates high molecular weight crosslinked products containing TIG3 TIG3 regulates keratinocyte differentiation MT Sturniolo et al 1995) . TG1 is selectively expressed in the suprabasal epidermal layers (Michel et al., 1992) and is unique in that it is anchored to the inner surface of the plasma membrane via myristyl and palmityl linkages attached to a cluster of cysteine residues present in the aminoterminus (Chakravarty and Rice, 1989; Chakravarty et al., 1990; Rice et al., 1990; Phillips et al., 1993; Steinert et al., 1996) . Elimination of TG1 expression results in an epidermal scaling phenotype (Kuramoto et al., 2002; Matsuki et al., 1998) that resembles the phenotype observed in lamellar ichthyosis, a human TG1 deficiency disease (Huber et al., 1995) . This is because TG1 activity is required for assembly of the envelope structure and other enzymes cannot substitute. Since normal TG1 function is essential for appropriate cornified envelope assembly and normal barrier function, investigators have taken a keen interest in mechanisms that regulate TG1 level and TG1 activity. It is clear that Ca 2 þ functions as a cofactor that is absolutely required for transglutaminase activity (Nemes et al., 1999b) . This finding is consistent with the existence of calcium binding sites that have been identified on several transglutaminases (Casadio et al., 1999; , the presence of an increasing gradient of free calcium in differentiating epidermis (Menon et al., 1985) , and the observation that increased extracellular calcium in cultured keratinocytes leads to increased TG1 activity (Green, 1980; Hennings et al., 1981; Green and Watt, 1982) .
In addition, agents have been identified that regulate TG1 level. These agents include calcium, glucocorticoids and vitamin D (Cline and Rice 1983; Gorodeski et al., 1990; Liew and Yamanishi, 1992; Rossi et al., 1998; Bikle et al., 2001) . In general, these agents regulate TG1 level via transcriptional mechanisms (Polakowska et al., 1999) .
However, apart from calcium, no protein or other candidate agent has been identified that may interact with TG1 to regulate crosslinking activity. A previous study showed that TIG3 expression in keratinocytes causes cell death and enhanced formation of cornified envelope-like structures (Sturniolo et al., 2003) . Our present study shows that TIG3, when expressed in keratinocytes, produces a substantial activation of transglutaminase activity. Transglutaminase activity in TIG3-positive cells appears many times greater than in empty vector infected cells -in spite of the fact that the TG1 level (protein and mRNA) is increased only twofold by TIG3. Efforts to demonstrate recombinant TIG3 interaction with TG1 were not successful (not shown), suggesting that TIG3 expression produces specific intracellular changes in keratinocytes, and that these changes are required for the TIG3-dependent increase in TG1 activity.
Regarding mechanism, our studies show that TIG3 co-precipitates with TG1, suggesting that TIG3 and TG1 may exist in a complex in cells. This finding is consistent with microscopic evidence suggesting TIG3 and TG1 codistribute (Sturniolo et al., 2003) . In contrast, an inactive TIG3 mutant, TIG3 1-134 , which lacks the carboxyl-terminal TIG3 membrane anchoring domain (Sturniolo et al., 2003) , does not co-precipitate with TG1. This finding suggests that TIG3 may need to associate with the plasma membrane in order to engage in a productive interaction with TG1, a suggestion that appears reasonable, considering that TG1 is a membrane-associated enzyme (Phillips et al., 1993; Kim et al., 1995; Steinert et al., 1996) .
Transglutaminase activation appears essential for TIG3-dependent cell death TIG3 could produce multiple responses in cells. Thus, an important question is the relative role of transglutaminase activity in mediating the TIG3-dependent biological response. In this context, we show that treatment with MDC, a substrate of transglutaminase, which acts as a competitive substrate to prevent endogenous substrates from having access to TG1, greatly attenuates the TIG3-assoicated response. Although MDC can have other effects in cells, it has been used as a competitive transglutaminase substrate inhibitor (Oliverio et al., 1997; Singh et al., 2003) . In this context, MDC serves as an amine donor and becomes crosslinked to endogenous protein substrates -ultimately preventing the formation of the larger crosslinked complexes associated with keratinocyte terminal cell death. The finding that MDC inhibits the TIG3-dependent response is consistent with the idea that transglutaminase activity is required for biological response.
TIG3 acts as a substrate for transglutaminase
Our studies also suggest that TIG3 functions as a substrate for TG1, further suggesting their close association. TIG3 is crosslinked to form dimers and high molecular weight complexes, and formation of these crosslinked products is inhibited by treatment with MDC. In addition, a mutant form of TIG3, TIG3 1-134 , which lack the carboxy membrane localizing domain, does not activate transglutaminase and does not become crosslinked. This is presumably because this mutant form does not localize to the plasma membrane. Biotincadaverine labeling studies indicate that TIG3 1-164 is an amine acceptor/glutamyl donor. TIG3 encodes five glutamine residues -Q 6 , Q 85 , Q 102 , Q 129 and Q 159 (Deucher et al., 2000) . Two of these glutamine residues, Q 129 and Q 159 , are near or within the plasma membrane anchoring domain and are likely to be localized close to the plasma membrane. The remaining residues are located in the flexible amino-terminal domain. Q 102 , Q 129 and Q 159 are interesting potential targets, as they are conserved in human, rat and mouse TIG3-like proteins (Deucher et al., 2000) , suggesting that they have a required function. Studies are presently underway to identify the transglutaminase-modified glutamyl residues.
Involucrin is a classical transglutaminase substrate and is utilized by transglutaminase when cells are stimulated to differentiate by the addition of calcium (Rice and Green, 1979; Banks-Schlegel and Green, 1981; LaCelle et al., 1998; Lambert et al., 2000; Nemes et al., 1999a) . It is interesting that involucrin does not function as a transglutaminase substrate in TIG3 1-164 -expressing cells. The absence of use of involucrin may reflect the rapid formation of envelopes that is observed in response to TIG3 expression, an ability of TIG3 to modify substrate utilization, or an inability of involucrin to localize to the plasma membrane in TIG3-positive cells. Additional studies will be required to address this issue. In some cases, increased intracellular calcium appears to be required for cornified envelope precursor movement to the cell periphery (Broome and Eckert, 2004 ). Although we have not measured the impact of TIG3 expression in intracellular calcium levels, it is important to note that all of these studies were performed in medium containing 0.09 mM calcium and it is possible that TIG3 activates TG1 without causing a global increase in intracellular calcium.
In conclusion, our studies identify a potential protein regulator of TG1 activity. We propose that TIG3 anchors to the inner surface of the plasma membrane and then translocates in the plane of the membrane until it locates TG1. TIG3 then interacts with lipid-anchored TG1 to increase TG1 activity and covalent crosslink formation. As part of this process, a fraction of the TIG3 becomes crosslinked. These events ultimately lead to cell death. An alternate explanation is that TIG3 promotes a local increase in calcium that, in turn, triggers the increase in transglutaminase activity. We cannot presently rule out this possibility and additional studies will be required to understand the mechanism of TIG3-dependent activation of transglutaminase.
Materials and methods
Adenovirus infection
The tetracycline-regulated recombinant adenovirus, tAd5-TIG3 1-164 , was constructed by cloning full-length TIG3 (TIG3 1-164 ) linked to the SV40 transcription terminator, into tAd5. This adenoviral vector contains a tetracycline operatorresponsive regulatory element linked to the cytomegalovirus promoter. This promoter is active in the presence of the tetracycline transactivator (TA) protein which is provided by coinfection with a second adenovirus, Ad5-TA (Sturniolo et al., 2003) . The ability of the TA protein to activate via the tetracycline operator is suppressed in the presence of tetracycline. tAd5-TIG3 1-134 was constructed by cloning the first 134 amino acids of TIG3 into tAd5. The titer of each virus, in plaque-forming units per microliter of viral stock, was determined by monitoring colony formation efficiency on 293 cells. An empty recombinant adenovirus tAd5-EV was constructed for use as a control and a green fluorescent protein (GFP)-encoding adenovirus, Ad5-GFP, was used to determine keratinocyte infection efficiency (Dashti et al., 2001a, b) . When treated at a level X10 plaque-forming units/cell all keratinocytes are infected (not shown).
Human foreskin keratinocytes were cultured in keratinocyte serum-free media (KSFM, Invitrogen, 0.09 mM calcium). Third passage cultures were plated at 15 000-20 000 cells/cm 2 . For infection, the cells were incubated with 25 MOI of tAd5-TIG3 1-164 , tAd5-TIG3 1-134 , or tAd5-EV in the presence of 5 MOI of Ad5-TA for 12 h in KSFM containing 2.5 mg of polybrene/ml. This time was sufficient to infect all cells. The cells were then washed and incubated in fresh virus-free KSFM for varying times prior to harvest.
MDC treatment
Primary human keratinocytes, growing on 20 cm 2 dishes, were infected with 25 MOI of either tAd5-TIG3 1-164 or tAd5-EV in the presence of 5 MOI of Ad5-TA. At 5 h postinfection, keratinocytes were treated with MDC, (Sigma D-4008) at 0-150 mM delivered from a 50 mM stock. After 12 h, the virus was removed and replaced with fresh MDC-supplemented medium. This medium was subsequently replaced every 24 h.
In vitro labeling of cell lysates with BC Extracts from cultured keratinocytes were homogenized in lysis buffer containing 10 mM HEPES, pH 7.4,. 1 mM EDTA, 1 mM DTT, 10 mg/ml PMSF and 0.2% Triton. In all, 50 mg of protein (150 ml) was combined with 50 ml of transglutaminase assay buffer (100 mM Tris-CI, pH 7.6, 3.2 mM CaCl 2 , 5 mM DTT, 10 mg/ml PMSF) in the presence or absence of 4 mM BC (Smethurst and Griffin, 1996) (Molecular Probes, B-1596) and incubated at 371C for 1 h. The reactions were terminated by addition of stop buffer (5 ml of 20 mM Tris-HCI, pH 7.5, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton, 2.5 mM sodium pyrophosphate, 1 mM b-glycerophosphate, 1 mM Na 3 VO4, 1 mg/ml leupeptin and 1 mM PMSF) and the resulting mixture was incubated with 50 ml of streptavidin agarose (Novagen, 69203) for 12 h at 41C. Streptavidin agaroseprotein complexes were collected by centrifugation, washed three times with stop buffer, and precipitated proteins were eluted by boiling in Laemmli buffer. In all, 25 mg equivalents of protein were electrophoresed in parallel with 10 mg protein equivalents of total extract. Biotin incorporation was monitored by immunoblot using ExtrAvidin-peroxidase conjugate (Sigma, E-2886, 1 : 1000 dilution), and TIG3 level was measured using anti-TIG3 (1:2000 dilution) (Deucher et al., 2000) .
Immunoprecipitation
Primary human keratinocytes, growing in 50 cm 2 dishes in KSFM, were transfected with 5 mg pcDNA3-TG1-flag with or without 5 mg of pcDNA3-TIG3 1-164 or pCA3-TIG3 1-134 using the Fugene-6 transfection reagent (Roche). The final DNA concentration was adjusted to 10 mg per transfection by addition of pcDNA3. At 24 h post-transfection, cells were homogenized in 1 Â cell lysis buffer containing 20 mM TrisHCl, pH 7.5, 150 mM NaCl, 1 mM Na 2 EDTA, 1 mM EGTA, 1% Triton, 2.5 mM sodium pyrophosphate, 1 mM b-glycerophosphate, 1 mM Na 3 VO 4 , 1mg/ml leupeptin, and 1 mM PMSF at 41C. A sample of total extract was dissolved in Laemmli sample buffer and the remaining extract was centrifuged at 15 000 g for 10 min to produce the supernatant fraction. For immunoprecipitation, supernatant samples containing equivalent amounts of protein (500 mg) were incubated overnight at 41C with anti-FLAG M2-Agarose (Sigma, A-2220). The precipitate was collected by centrifugation and washed three times for 30 min at 41C with 1 Â cell lysis buffer. Bound proteins were eluted by boiling in Laemmli sample buffer. An equal number of cell equivalents of total extract and six times this number of cell equivalents of immunoprecipitate were electrophoresed on a 12% denaturing polyacrylamide gel. The gels were immunoblotted with rabbit anti-TIG3 (dilution 1 : 2000) (Deucher et al., 2000) , mouse anti-b-actin (Sigma, 
RT-PCR
Subconfluent primary human keratinocytes, growing on 20 cm 2 dishes, were infected with 25 MOI of either tAd5-TIG3 1-164 or tAd5-EV in the presence of 5 MOI of Ad5-TA. At 24 h postinfection, the cells were trypsinized and mRNA was isolated using the Oligotex mRNA Mini Kit (Qiagen, #70022). RT-PCR reactions were performed using the indicated primers : TIG3 1-164 (5 0 -GCGAATTCTATGGCTT CGCCACAC CAAGAGC-3 0 , 5 0 -CGTCTAGATCAGGCT GTTGCTTTTTTTTGGTATC-3), human TG1 (5 0 -TGAATA GTGA CAAGGTGTACTGGCA-3 0 , 5 0 -TACGACGAGTTA CA GAGTCCGGTG-3 0 ), human involucrin (5 0 -CTCCAC CAAAGCCTCTGC-3 0 , 5 0 -CTGCTTAAGCTGCTGCTC-3 0 ) and human b-actin (5 0 -TGACGGGGTCACCCACACTGT GCCCATCTA-3 0 , 5 0 -CTAGAAGCATTTGCGGTGG AC GATGGAGGG-5 0 ). RT-PCR was performed with 50 ng of mRNA per 50 ml reaction using the Titan One Tube RT-PCR System (Roche, #1888 382). The reverse transcriptase and polymerase chain reaction conditions were exactly as specified by the manufacturer. Half of each reaction mixture was then analysed by electrophoresis on a 1.8% agarose gel and staining with ethidium bromide.
Abbreviations TIG3, tazarotene-induced protein 3; TG1, type 1 transglutaminase.
